Drug intelligence / Profile preview

marbofloxacin

Development stage
Unknown
Lead developer
Vetoquinol
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Otic
01

Overview

Marbofloxacin is a third-generation fluoroquinolone antibiotic used exclusively in veterinary medicine. It is a synthetic, broad-spectrum, bactericidal agent effective against a wide range of gram-negative and some gram-positive bacteria. Its primary mechanism of action involves inhibition of bacterial DNA gyrase (a type II topoisomerase), which disrupts DNA replication and transcription, leading to rapid bacterial cell death. Marbofloxacin is approved for use in dogs and cats for the treatment of infections associated with susceptible bacteria, particularly those affecting the skin, soft tissue, urinary tract (bladder and kidneys), and prostate. It may also be used off-label in other species such as birds, rabbits, reptiles, and for conditions like leishmaniasis or hemoplasmosis[1][2][5]. The drug should not be administered to growing animals due to the risk of cartilage abnormalities[6][7].

Brand names
ZeniquinMarbocylForcylMarbo vetAristosBofloxKelacylAurizon
Other names
marbofloxacin
02

Targets

Topo IV (Bacterial Topoisomerase IV)DNA gyrase

Beyond the preview

Go deeper on marbofloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on marbofloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call